Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists

György Németh; Réka Csehi

doi:10.3389/fpsyt.2022.1038627

Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists

Front Psychiatry. 2022 Sep 28:13:1038627. doi: 10.3389/fpsyt.2022.1038627. eCollection 2022.

Authors

György Németh^{1

2}, Réka Csehi^{1

2}

Affiliations

¹ Gedeon Richter Plc, Budapest, Hungary.
² Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary.

No abstract available

Keywords: D2-D3 receptors; dopamine partial agonist; overlapping symptoms; psychiatry; psychopharmacology; real world data (RWD); real-world evidence (RWE); transdiagnostic approach.

Publication types

Editorial